cs.CYJun 18, 2026

Explainable Artificial Intelligence For The Detection and Characterisation of Stage B Heart Failure

Authors: Ahmed M Salih, Emer Brady, Ranjit Arnold, Gaurav Gulsin, Huiyu Zhouyb, Anvesha Singh, Gerry McCanna

Abstract

Stage B heart failure is characterized by asymptomatic structural or functional cardiac abnormalities. Identifying individuals at this stage is clinically important, as early detection may enable targeted interventions to prevent progression to symptomatic disease. Explainable artificial intelligence (XAI) may support early detection, transparent risk stratification, and selection of clinically actionable interventions. This review examines the use of XAI in detecting and characterizing stage B heart failure. A literature search of Web of Science, Scopus, and PubMed was conducted on 27 March 2026. Studies were included if they applied AI with XAI techniques to stage B heart failure. After screening, 20 studies were included. Data on modalities, outcomes, demographic reporting, and XAI methods were extracted and synthesized. SHAP was the most commonly used method, followed by LIME, saliency maps, and Grad-CAM; however, XAI adoption was inconsistent, with some studies relying on limited or ad hoc interpretability approaches. Notably, none compared explanations across sex or ethnic subgroups, despite evidence of subgroup differences in disease burden. Evaluation of XAI outputs was often insufficient: some studies did not assess explanations, while others relied only on literature-based comparisons, introducing potential bias. These limitations suggest explainability was not systematically validated or leveraged to support robust and fair clinical inference. XAI shows promise for improving transparency in stage B heart failure identification, but current implementations remain limited. Key gaps include limited consideration of sex and ethnicity, absence of subgroup-specific analyses, inconsistent evaluation, and lack of external validation, all of which constrain generalisability and clinical adoption.

Explore similar work

CardsList
Jul 27, 2026cs.CY

Beyond Local Inspection: Global, Guideline-Grounded Evaluation of Post-hoc XAI Methods for ECG Classification

Explainable AI (XAI) is used to assess whether artificial intelligence models rely on meaningful patterns, yet explanations that appear plausible for individual predictions may systematically misrepresent model behavior. This is particularly problematic in medicine, where models may rely on irrelevant signal characteristics rather than disease-specific patterns without being recognizable. We address this challenge using electrocardiogram (ECG) data, for which clinical guidelines provide explicit knowledge about diagnostically relevant signal regions. We introduce a global, guideline-grounded framework that aggregates explanations across heartbeats to evaluate them against clinically defined regions of interest. Using four binary classifiers trained on PTB-XL, we assess 13 gradient-based methods across two categories of patterns: low-amplitude segments and high-amplitude QRS morphology. Our results reveal a systematic failure of methods transferred from computer vision. Their explanations often follow signal amplitude rather than clinical relevance, with mean Spearman correlations up to 0.69, leading them to overlook diagnostically decisive low-amplitude regions. For ischemia, LRP-εε assigns only 4.6% of relevance to the ST segment, compared with 63.8% for LRP-SIGN. Nine of 13 methods fall below chance for at least one condition, indicating inconsistent reliability across patterns. These findings show that global, domain-grounded evaluation can uncover systematic explanation failures not obvious from sample-level heatmaps.
Nils Gumpfer, Michael Guckert, Samuel Sossalla +2
XaiExplainable Artificial IntelligencePost-HocQuantile Regression
AskPDF
May 19, 2026cs.LG

ExECG: An Explainable AI Framework for ECG models

Deep learning has enabled ECG diagnostic models with strong performance in tasks such as arrhythmia classification and abnormality detection. However, accuracy alone is insufficient for clinical deployment because it does not explain why a specific output was produced, limiting justification, error analysis, and trust. Although ECG XAI has been extensively investigated and steadily improved, practical pipelines and reporting conventions vary across studies, hindering reuse and reproducibility. To address these issues, we present Explainable AI framework for ECG models (ExECG), a Python framework that provides a three-stage pipeline: Wrapper standardizes access across heterogeneous ECG formats and intermediate representations, Explainer unifies diverse XAI methods under a shared execution protocol, and Visualizer supports consistent cross-method comparison within a unified interface. We demonstrate end-to-end usage with concise examples and two case studies, highlighting interoperable and reproducible ECG explainability.
Jong-Hwan Jang, Yong-yeon Jo
ElectrocardiogramXai
AskPDF
May 23, 2026cs.AI

Associations between echocardiographic traits and AI-ECG predictions of heart failure

Artificial intelligence-enabled electrocardiography (AI-ECG) can detect heart failure (HF), including disease not captured by left ventricular ejection fraction (LVEF), but the cardiac phenotypes underlying model predictions remain unclear. We therefore investigated whether AI-ECG-predicted HF risk aligns with established echocardiographic measures of myocardial dysfunction, remodelling, and filling pressures. We retrospectively analysed ECG and echocardiography data from 8147 patients who underwent both examinations within three days at Akershus University Hospital between 1 January 2023 and 1 June 2025. A previously validated AI-ECG model for HF detection was applied to all ECGs. Spearman's rank correlation ρρ quantified associations between echocardiographic parameters and AI-ECG risk. Subgroup analyses were performed by sex and left ventricular ejection fraction (LVEF). External validation included 36,286 ECG-echocardiography pairs from Columbia University Irving Medical Center. Global longitudinal strain (GLS) showed the strongest correlation (ρρ=0.57), followed by mitral annular plane systolic excursion (MAPSE) (ρρ=-0.49) and LVEF (ρρ=-0.45). In patients with LVEF>50%, correlations remained substantial for GLS, MAPSE, and diastolic-related parameters. Volumetric left ventricular indices correlated less strongly in women, whereas diastolic indices showed stronger correlations in women than in men. Physiological validation showed that AI-ECG HF risk predictions align primarily with measures of systolic function, particularly global longitudinal strain, while also capturing diastolic-related abnormalities in patients with preserved LVEF. This approach may improve clinical interpretability and identify opportunities for model refinement.
Elias Stenhede, Eivind Bjørkan Orstad, Torbjørn Omland +2
CardiacElectrocardiogramEchocardiographyCardiac SegmentationAssociationsContinuum Dynamics
AskPDF